Strategies for microbiological contamination control in Api (Active Pharmaceutical Ingredients) and finished product Manufacturing: Compliance with USFDA guidelines
Journal of Advances and Scholarly Researches in Allied Education · 01.10.2025 · 22 (5) · 643-656
DOI: 10.29070/9nyy5z35 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Advances and Scholarly Researches in Allied Education, online erschienen am 01.10.2025. Verfasst von Som Prakash Vats und 1 weiteren Autor:innen.
Abstract (Originalsprache)
In many cases, the quality of the finished product depends on the microbiological properties of the medicinal components. Manufacturers are expected by the USFDA to quantify and describe the bioburden of their goods. This page describes the USFDA's and compendia's concerns over microbiological contamination. Also covered in this article are ways to identify microbial contamination, how to get rid of it, and where it comes from.
Zitieren
APA
Vats, S. P., & Kumar, E. (2025). Strategies for microbiological contamination control in Api (Active Pharmaceutical Ingredients) and finished product Manufacturing: Compliance with USFDA guidelines. Journal of Advances and Scholarly Researches in Allied Education, 22(5), 643-656. https://doi.org/10.29070/9nyy5z35
Vancouver
Vats SP, Kumar E. Strategies for microbiological contamination control in Api (Active Pharmaceutical Ingredients) and finished product Manufacturing: Compliance with USFDA guidelines. Journal of Advances and Scholarly Researches in Allied Education. 2025;22(5):643-656. doi:10.29070/9nyy5z35
BibTeX
@article{Vats2025,
author = {Vats, Som Prakash and Kumar, Eshendra},
title = {Strategies for microbiological contamination control in Api (Active Pharmaceutical Ingredients) and finished product Manufacturing: Compliance with USFDA guidelines},
journal = {Journal of Advances and Scholarly Researches in Allied Education},
year = {2025},
volume = {22},
number = {5},
pages = {643--656},
doi = {10.29070/9nyy5z35}
}
EUVIMED